Mulmit

Kymera Therapeutics, Inc.Kymera Therapeutics, Inc.

KYMR Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3139,211,000-349,399,000311,351,000-3.69
2024-12-3147,072,000-261,635,000223,858,000-2.98
2023-12-3178,592,000-165,530,000146,962,000-2.52
2022-12-3146,826,000-161,256,000154,808,000-2.87
2021-12-3172,832,000-100,530,000100,217,000-2.09

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-04Adams BrianChief Legal Officer1,209
2026-09-04Adams BrianChief Legal Officer3,025
2026-09-04Adams BrianChief Legal Officer2,137
2026-07-27Rooney TerenceChief Medical Officer38,000
2026-07-27Rooney TerenceChief Medical Officer76,000
2026-07-07Mainolfi NelloChief Executive Officer50,000
2026-07-07Mainolfi NelloChief Executive Officer50,000
2026-07-07Mainolfi NelloChief Executive Officer45,559
2026-07-07Mainolfi NelloChief Executive Officer4,441
2026-07-01Goodman NoahChief Business Officer3,389
2026-07-01Mainolfi NelloChief Executive Officer80,000
2026-07-01Mainolfi NelloChief Executive Officer1,883

8-K events

FiledItems
2026-08-05Results of operations · Financial statements and exhibits
2026-07-27Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-06-25Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-24Submission of matters to a vote
2026-06-08Officer or director change
2026-04-30Results of operations · Financial statements and exhibits
2026-03-27Amendments to charter or bylaws · Financial statements and exhibits
2026-02-26Entry into a material agreement · Termination of a material agreement · Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.